30 Years of Fellowships

The UNC Eshelman School of Pharmacy, in cooperation with PPD, United Therapeutics, Quintiles, and GlaxoSmithKline, sponsors two-year fellowships in clinical research and drug development. Ideal candidates will have obtained a PharmD, PhD, or MD. Residency training is preferred but not required.

Each fellowship provides:

• Orientation to all aspects of the drug development process (e.g., preclinical and clinical development)
• Experience in developing, reviewing, and composing protocols, study reports, and regulatory submissions
• Exposure to the selection, set-up, and monitoring of clinical sites participating in Phase I/ II/III and/or pharmacokinetic studies

Fellows will develop expertise in one or more of the following areas:

• Proposal development
• Regulatory affairs
• Clinical site monitoring
• Data analysis including PK and PD studies in healthy subjects, patient populations, or relevant in vitro/pre-clinical models
• Drug assay methodologies
• Biostatistical analysis

Fellows will participate in clinical research projects with faculty at the School and with members of GlaxoSmithKline, PPD, and United Therapeutics. Fellows will design, initiate, conduct and analyze research project(s) as part of the learning experience.

Fellows may participate in selected course work in:

• Clinical research methods
• Clinical study design
• Biostatistics
• Advanced pharmacokinetics and pharmacodynamics
• Genomics
• Data management
• Advanced therapeutics
• Drug metabolism
• Molecular biology

What's Included

Fellowships start July 1 and offer:

• A competitive stipend
• Health insurance and a standard UNC benefits package
• Opportunities for professional travel